NKAP and type 2 diabetes mellitus: The methylation of NKAP and SPESP1 promoters decreases their expression, and the silencing of Nkap and Apln in clonal cells reduces GSIS (Sharp et al., 2011), suggesting that differential DNA methylation may explain sex differences in insulin secretion and T2D risk.